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Abstract: Congenital esophageal atresia with or without tracheoesophageal fistula (CEA ± TEF) is
a relatively common malformation that occurs in 1 of 2500–4500 live births. Despite the refinement of
surgical techniques, a considerable proportion of children experience short- and long-term respiratory
complications, which can significantly affect their health through adulthood. This review focuses
on the underlying mechanisms and clinical presentation of respiratory morbidity in children with
repaired CEA ± TEF. The reasons for the short-term pulmonary impairments are multifactorial
and related to the surgical complications, such as anastomotic leaks, stenosis, and recurrence of
fistula. Long-term respiratory morbidity is grouped into four categories according to the body
section or function mainly involved: upper respiratory tract, lower respiratory tract, gastrointestinal
tract, and aspiration and dysphagia. The reasons for the persistence of respiratory morbidity to
adulthood are not univocal. The malformation itself, the acquired damage after the surgical repair,
various co-morbidities, and the recurrence of lower respiratory tract infections at an early age can
contribute to pulmonary impairment. Nevertheless, other conditions, including smoking habits and,
in particular, atopy can play a role in the recurrence of infections. In conclusion, our manuscript
shows that most children born with CEA ± TEF survive into adulthood, but many comorbidities,
mainly esophageal and respiratory issues, may persist. The pulmonary impairment involves many
underlying mechanisms, which begin in the first years of life. Therefore, early detection and
management of pulmonary morbidity may be important to prevent impairment in pulmonary
function and serious long-term complications. To obtain a successful outcome, it is fundamental to
ensure a standardized follow-up that must continue until adulthood.
Keywords: congenital esophageal atresia; pediatric pulmonology; respiratory morbidity;
tracheoesophageal fistula
1. Introduction
Congenital esophageal atresia with or without tracheoesophageal fistula (CEA ± TEF) is
a relatively common malformation that occurs in 1 in 2500–4500 live births, with males having a slightly
increased incidence [1–4]. It is mostly a sporadic event with low familial recurrence. Moreover,
in approximately 50% of cases, CEA± TEF is associated with additional anatomic anomalies [5]. Heart,
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genitourinary, gastrointestinal, musculoskeletal, and central nervous system defects are encountered in
35%, 24%, 24%, 13%, and 10% of cases, respectively [6]. Most infants have more than one malformation.
In 36% of cases, these may occur as part of the VACTERL spectrum (vertebral anomalies, anorectal
atresia, congenital heart malformations, tracheoesophageal fistula, renal abnormalities, and limb
defects) or CHARGE syndrome (coloboma, heart defects, atresia choanae, retardation of growth
and/or development, genital hypoplasia, and ear deformities). Trisomies of chromosomes 18 and 21,
Di George syndrome and Pierre Robin syndrome are other significant risk factors for CEA ± TEF [7–9].
These underlying diseases may be detected before birth.
Usually, symptoms of CEA ± TEF appear in the first hours of life because the neonate is
unable to swallow saliva and needs repeated suctioning to aspirate oral secretions. However, oral
feeding is not possible because it causes emesis, cough, and respiratory distress. Treatment must
be implemented as soon as possible and consists of early surgical correction of CEA by primary
anastomosis of the esophageal stumps and closure of the TEF, if it is present, as well as by specific
therapies for management of the complications. The thoracotomy repair remains the most common
approach [10], although in recent years, approximately 10% of all cases have been corrected by
minimally invasive surgery via thoracoscopy [11], which seems to offer advantages in terms of
low rates of rib fusion and subsequent scoliosis [12]. The improvement of surgical techniques in
children with CEA has been associated with an overall increase in survival rates, which now exceeds
90% [13]. However, despite the refinement of surgical techniques, a considerable proportion of children
experience short- and long-term respiratory complications, which can significantly affect their health
through adulthood [14]. Generally, short-term pulmonary sequelae occur in the early postoperative
period, whereas long-term morbidity is mostly associated with the original malformation itself and
its consequences on other organs. This review focuses on the underlying mechanisms and clinical
presentation of respiratory morbidity in children with repaired CEA ± TEF.
2. Early Respiratory Morbidity
The reasons for the short-term pulmonary impairments are multifactorial and related to the
surgical complications, such as anastomotic leaks, stricture, and recurrence of fistula [15]. Anastomotic
leakage generally occurs in 10–20% of the cases [16,17] and can result from the weakness of the
segment related to an excess of anastomotic tension or recurrent infections [18]. Leakage is one of the
most important risk factors for life-threatening complications, including serious systemic infections,
severe pneumonia, atelectasis, pleural effusion, and tension pneumothorax [19,20]. In a study by Zhao
et al., conservative management (i.e., chest-tube drainage, suspension of feedings, total parenteral
nutritional support, and administration of broad-spectrum antibiotics) was applied, and anastomotic
leaks developed in 21/85 neonates (25%) with CEA [21]. The authors isolated mainly highly resistant
Gram-negative bacteria (i.e., Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas
aeruginosa, Enterobacter cloacae) from the pleural drainage fluid of 12/21 newborns. To prevent
anastomotic leaks, some authors have suggested the early use of broad-spectrum antibiotics and
continuous suctioning of the upper pouch, parenteral nutrition, or trans-anastomotic tube feeding and
postoperative elective ventilatory support [22,23].
The anastomotic stricture is another common esophageal complication (30–50% of cases),
which can be a risk factor for short-term respiratory impairment. It is characterized by
an intrinsic circumferential narrowing of the esophageal lumen, which is related to the presence
of gastro-esophageal reflux (GER), tension of the anastomosis, and long-gap atresia [24]. The common
clinical presentations of anastomotic stricture include dysphagia, regurgitation, aspiration pneumonia,
and chronic respiratory tract infections [25]. The best treatment remains esophageal dilatation,
although some children may require more than one maneuver because the strictures usually recur [26].
Endoscopic steroid injection, systemic steroid administration, or the topical application of mitomycin C
are considered adjuvant therapeutic strategies in addition to the dilation of the recurrent or refractory
strictures [27].
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Recurrent TEF is a frequent (5–10%) complication of CEA ± TEF repair [28]. It generally occurs
in the early postoperative period but can sometimes remain undiagnosed for many years. It is more
frequent in the case of anastomotic leakage, but infection may also play a role in the recurrence [29].
Manifestations of recurrent TEF include chronic cough, choking, cyanosis with feeding, dyspnoea,
wheezing, and recurrent pneumonia [30]. In the case of clinical suspicion, tracheobronchoscopy
and esophagography are mandatory. Spontaneous closure is rare, and therefore, this complication
requires a new surgical intervention [31]. Table 1 summarizes the reasons for the short-term pulmonary
impairments and their clinical manifestations.
Table 1. Reasons for the short-term pulmonary impairments and clinical manifestations in children
with repaired congenital esophageal atresia and tracheoesophageal fistula.
Reasons Clinical Manifestations
Anastomotic leaks Serious systemic infections
Severe pneumonia
Cyanotic spells
Atelectasis
Pleural effusion
Tension pneumothorax
Stricture Dysphagia
Regurgitation
Aspiration pneumonia
Chronic respiratory tract infections
Recurrence of fistula Chronic chough
Choking
Cyanotic spells or cyanosis with feeding
Dyspnoea
Wheezing
Recurrent pneumonia
3. Long-Term Respiratory Morbidity
With the improvement of surgical and post-surgical care, most children with CEA ± TEF
reach adulthood. However, a substantial amount of cases suffers from respiratory problems
including bronchiectasis, with a frequency significantly higher than those without CEA ± TEF [28].
These findings can persist into adulthood, require gastric tube dependence and are likely to be
multifactorial, depending either on the original malformation itself or on the consequences of
the malformation in other organs. A study conducted in 101 adult patients who had undergone
surgical repair of CEA with or without TEF showed that after 22–56 years of follow-up they had
more respiratory symptoms and infection, as well as asthma and allergies, and more often poorer
respiratory symptom-related quality of life than age-matched controls [32]. Generally, long-term
respiratory morbidity is grouped in four categories according to the body section or function primarily
involved: upper respiratory tract, lower respiratory tract, gastrointestinal tract, and aspiration and
dysphagia (Table 2).
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Table 2. Long-term respiratory morbidity in patients with repaired congenital esophageal atresia and
tracheoesophageal fistula.
Category Clinical Presentation
Upper respiratory tract involvement Tracheomalacia
Vocal cord dysfunction
Lower respiratory tract involvement Chest wall deformities
Bronchiectasis
Gastrointestinal involvement Esophagus dysmotility
Gastro-esophageal reflux disease
Aspiration and dysphagia Swallowing problems
Feeding difficulties
4. Upper Respiratory Tract Involvement
4.1. Tracheomalacia
Tracheomalacia is a common finding in children who have undergone surgery for CEA ± TEF,
with a prevalence ranging from 37.5% to 75% of patients [33,34], and the more severe expression of the
disease is reported in 11–33% of children [35]. The impaired cartilage integrity usually corresponds
to the TEF entrance, but it can sometimes be more extensive [36]. Tracheomalacia is secondary to
congenital defect in tracheal cartilage development and tracheal weakness results in dynamic tracheal
collapse, especially during the expiratory phase when the intrathoracic pressure physiologically
exceeds the intraluminal tracheal pressure [37].
The functional impairment depends on the length of the involved segment and the degree
of airway collapse. The typical symptoms are brassy cough and expiratory stridor. In most
cases, they are self-limiting, with spontaneous resolution in the first months/years of life [38].
However, in the most serious cases, tracheomalacia can interfere with ventilation, leading to severe
respiratory obstruction, especially during crying, when very high intrathoracic pressure is generated.
Additionally, during feeding the dilation of the esophagus may worsen the tracheal collapse. Moreover,
severe tracheomalacia can significantly impair the clearance of respiratory secretions, resulting in
a non-efficacious cough and ineffective elimination of secretions [39]. In severe cases, affected children
present with feeding difficulties, recurrent pulmonary infections with respiratory failure, and severe
episodes of upper respiratory tract obstruction until life-threatening crises of apnea occur—the so-called
‘apneic spells’. ‘Apneic spells’, also known as cyanotic spells, blue spells, dying spells, or apparent
life-threatening events, refer to a bluish tone visible in the mucosal membranes and skin caused by
an oxygen decrease in the peripheral circulation [40]. Although this decrease may be transient
and benign, it may also be indicative of a severe underlying problem that requires immediate
intervention. Significant airflow reduction can be successfully treated by maintaining the patency of
the upper airways through non-invasive positive pressure ventilation [41]. In severe cases, the surgical
intervention of aortopexy is recommended [42]. More rarely, patients with very severe tracheomalacia
unresponsive to surgical correction may require long-term tracheostomy with a long cannula to support
tracheomalacia as the children grow older [43].
4.2. Vocal Cord Dysfunction
In children with aero-digestive malformations, vocal cord paresis or paralysis, although
uncommon, can occur after surgical repair [44–48]. Bilateral paralysis is a potentially life-threatening
condition because it can lead to complete airway obstruction, requiring long-term tracheostomy
placement, whereas the mildest cases may resolve spontaneously [44–48]. Moreover, vocal cord
paralysis can also be lateralized and not lead to airway obstruction [44–48]. However, all these children
are at increased risk of swallowing dysfunction and aspiration [47,48]. Their ability to swallow has to
be systematically evaluated to reduce risks of respiratory complications.
Int. J. Environ. Res. Public Health 2017, 14, 1136 5 of 13
The incidence of vocal cord dysfunction in patients who have undergone surgical repair varies
significantly among studies and is reported in 3% to 30% of the cases according to the criteria used to
evaluate the problem [44–46]. A recent Italian retrospective analysis documented that postoperative
vocal cord paralysis is more common in patients with type B CEA (CEA, with a proximal TEF, or a TEF
connecting between the upper pouch of the esophagus and the trachea) and E CEA (TEF connecting
between the esophagus and the trachea, without CEA) [47]. Moreover, the thoracoscopy repair seemed
to be associated with a higher rate of vocal cord impairment [48]. However, it is likely that not all
these cases are caused by the surgical repair due to prolonged intubation or recurrent laryngeal or
vagus nerve injury during surgery. Many cases can be the result of a congenital malformation [44].
Differentiation between congenital and acquired cases is difficult because evaluation of vocal cord
function via laryngoscopy is not routinely performed pre-operatively, although some authors suggest
that the procedure be performed before CEA ± TEF repair [49].
5. Lower Respiratory Tract Involvement
Chest Wall Deformities
The standard open technique of postero-lateral thoracotomy is commonly employed in infants
for repair of CEA ± TEF [50]. This surgical approach, requiring rarely muscle and rib resection,
is associated with many long-term issues with an impact to the chest wall, such as scoliosis, shoulder
girdle muscle weakness and chest wall deformity. In particular, severe scoliosis has been reported in
a percentage ranging from 6% to 50% of cases, generally five or more years after the thoracotomy [51,52].
The chest wall deformity has an adverse effect on lung growth and may cause restrictive lung disease
with long-term development of chronic respiratory insufficiency.
The more recent thoracoscopic approach using minimally invasive techniques has significantly
reduced the extent of the chest wall complications [53]. However, vertebral anomalies may also be
pre-existing, as a part of syndromic pattern. In a large study of adult patients, vertebral anomalies
were detected in 45% of the cases, most commonly in the cervical spine (38% of the patients). The most
significant risk factor for vertebral anomalies was any additional anomaly [5].
6. Gastrointestinal Involvement
Esophagus Dysmotility and Gastro-Esophageal Reflux Disease (GERD)
Gastro-esophageal reflux disease (GERD) is one of the most frequent complications encountered
in patients with repaired CEA ± TEF, with a reported prevalence ranging from 22% to 55% [54,55].
The primary symptoms are recurrent vomiting, heartburn, regurgitation, growth failure in children
and an apparent life-threatening event in infants. Moreover, although no study has evaluated the real
correlation between GERD after CEA ± TEF repair and pulmonary symptoms, GERD is associated,
especially in children, with pulmonary complications, including cough (8–75%), wheezing (14–40%),
bronchitis (14–74%), recurrent pneumonia (5–50%), atelectasis (up to 90%), bronchiectasis (17%), and
airway hyperreactivity (33–65%) [55,56].
Many structural and functional factors are probably involved in the pathogenesis of GERD after
surgery, although a congenital and permanent impairment in the motor function of the esophagus
seems to be the most relevant condition. In a recent review, Tovar and Fragoso underlined the
abnormality of extrinsic and intrinsic esophageal innervations, leading to defective motor function and
sphincters [56]. However, post-surgical modifications of the gastro-esophageal junction, such as
shortened intra-abdominal segment and reduction of the His angle, may play a role in GERD
development [57]. Symptoms of GERD can appear immediately after surgical repair or become
evident some months later but may be a lifelong problem. Koivusalo et al. studied 61 patients who
underwent repair for CEA with endoscopy and pH-metry and found GERD in 16.3%, 39.3%, 44.2%,
51.2%, and 44.4% of the patients at 6 months, 1 year, 3 years, 5 years, and 10 years, respectively [58].
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In adults with CEA ± TEF, respiratory problems become less frequent, whereas gastro-intestinal
symptoms remain very common [59]. In particular, symptoms of dysphagia and heartburn are
reported in a high percentage of cases, with a frequency of 39–85% and 34–63%, respectively [60–62].
There is also evidence that persistent GERD with chronic acid exposition is associated with permanent
scarring and damage to the esophagus, which can lead to columnar metaplasia and increase the
risk of esophageal cancer [63]. In two studies, this has been described with a prevalence of 0.8%
and 2.6%, respectively. Moreover, biopsy proven Barrett’s esophagus is reported in five studies
with a prevalence ranging from 1.1% to 11.3% with a pooled estimated prevalence obtained from
a meta-analysis of various studies of 6.4%. For these reasons, long-term periodic monitoring is
advisable also in adulthood [64]. The gold standard tests for GERD diagnosis are 24-h period pH-test
and pH-impedance test, in which first test monitors the esophageal acid exposition and the second
test quantifies and correlates the non-acid reflux with symptoms. In a recent study conducted on
22 children treated for CEA, it was shown that in children younger than one year, the majority of
clinically-relevant refluxes were not of acid [65]. In another recent retrospective study, approximately
50% of children had GERD detected only with multichannel intraluminal impedance-pH monitoring,
which has been underestimated if only conventional pH monitoring has been used [66]. In select cases,
when pH monitoring shows normal results and GERD symptoms persist, a barium contrast study and
endoscopy are also required. In addition to general non-surgical management of GERD including
sleeping position and type of food, gastric acid suppression with proton pump inhibitors is the first-line
treatment for GERD, but the drug of choice, the dosage, the optimal length, the success rate and the
risks of this therapy are not well determined. Moreover, no drugs are effective in the treatment of
non-acid reflux and surgical fundoplication becomes necessary up to 45% of patients, particularly
in cases with refractory anastomotic stricture and in those with pure and long-gap CEA ± TEF [61].
Nevertheless, this procedure can worsen distal esophageal motility and can lead to a worsening of
respiratory complications [60].
7. Aspiration and Dysphagia
Swallowing and Feeding Problems
Dysphagia is a common symptom related to CEA, with an incidence, in children and
adolescents who underwent surgical repair, ranging between 21% and 84% [61,63,67]. Like GERD,
dysphagia recognizes a multi-factorial etiology, including congenital esophageal dysmotility, GERD,
and esophagitis. Additionally, surgical intervention can damage the esophagus smooth muscle
and innervation and may lead to recurrent stenosis and esophageal diverticula, which, in turn,
can contribute to dysphagia [61]. This condition is often associated with swallowing dysfunction,
heartburn, regurgitation, and early sensation of postprandial fullness.
Many children with dysphagia need to eat slowly, mostly avoiding solid foods, and need to
drink a substantial amount of water to help swallowing [67,68]. In some cases, feeding refusal can
influence nutritional status and growth development. In these severe cases esophageal manometry
can be used. In a recent retrospective evaluation of 75 children with repaired CEA, malnutrition and
stunting were reported in 9% of cases, respectively, especially in the first years of life [69]. There is also
a relationship between dysphagia and the development of recurrent lower respiratory tract infections
because dysphagia can cause tracheal aspiration. Aspiration is an underrecognized cause of feeding
difficulty in children with EA [28,59]. Using a feeding questionnaire, Puntis et al. showed the presence
of coughing or choking during feeds in 20% (25/124) of children born with CEA± TEF, and Smith et al.
reported the presence of food sticking in the esophagus in 18/23 (78%) of children who underwent
repair [70–72].
If dysphagia is suspected, an endoscopic evaluation of the esophagus should be performed
to identify anatomical anomalies, such as strictures, diverticula, or esophagitis signs. Esophageal
manometry is also recommended for identifying esophageal dysmotility, especially in those patients
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with normal endoscopic features [56]. To assess the presence of aspiration during swallowing,
the videofluoroscopic swallow study is helpful in differentiating functional and morphological
disorders that are strictly related to aspiration and can influence the decision about continued
therapy [68].
Currently, there are no shared interventions to prevent swallowing and feeding problems;
however, a specialized swallowing evaluation as well as consultation with speech therapist and
nutritionist before starting full oral feeding is suggested to assess the safety of oral feeding and to
reduce tracheal aspirations. Additionally, non-surgical management of dysphagia can be considered,
although there is no focused therapy for this condition, and the treatment is dependent on the
underlying cause [58]. In cases of severe malnutrition or aspiration during swallowing, temporary
gastrostomy for aggressive nutritional management should be considered [39]. Generally, dysphagia
has a good prognosis and improves with time. In a recent retrospective cohort study conducted in
111 patients with CEA, dysphagia was reported in 55% of patients <1 year, and in those aged between
5–11 years, the prevalence rate decreased to 17% and remained substantially stable in the age group
12–18 years. The severity of the disease tended to decrease with age [73].
8. Pulmonary Morbidity in Adulthood
Respiratory complications are very common in patients with repaired CEA ± TEF, although it is
difficult to estimate the real prevalence of pulmonary involvement because of differing study designs
and different surgical approaches over the years. In a prospective study conducted on 31 teenagers,
Malmström et al. documented the occurrence of at least one pneumonic episode after surgical repair
in 52% of cases [74]. Another study in 3479 patients with CEA ± TEF treated at 43 children’s hospitals
documented 52% of hospital re-admissions for pneumonia in the first two years after the surgical
repair, including 26% of patients with three or more pneumonia episodes [75]. A recent systematic
first-year survey found occurrence of respiratory symptoms in 37% of the 307 CEA patients born in
2008 and 2009 and re-hospitalization for respiratory diseases in 28% [76]. Finally, a large observational
study including 334 patients showed that the most hospital admissions due to respiratory illness
occurred in children aged less than five years and that patients with GERD and low birth weight were
more likely to be admitted [77].
Generally, although less frequently, recurrent respiratory infections tend to persist over time.
However, wide differences in the prevalence of respiratory symptoms in adulthood has been reported,
depending on the case series considered. Kovesi et al. reported a decrease over time in the prevalence
of either bronchitis (75% in infancy and 40% over 15 years of age) or pneumonia (30% in infancy and
6% over 15 years) [28]. In a series of 101 adults treated for CEA between 1947 and 1985, 11% of patients
reported current respiratory symptoms compared to 2% of healthy controls; a history of pneumonia
and bronchitis were reported in 56% and 70% of patients (20% and 50% of controls), respectively [78].
Finally, in the study by Chetcuti et al., episodes of pneumonia after the age of 18 years were reported in
6% of the cases, and current bronchitis was reported in 14% of 125 adult patients born before 1969 [79].
The reasons for the persistence of respiratory morbidity to adulthood are not univocal (Table 3).
The malformation itself, the acquired damage after the surgical repair, the various co-morbidities
previously analyzed and the recurrence of lower respiratory tract infections at an early age can
contribute to pulmonary impairment. Nevertheless, other conditions, including smoking habits and
atopy can play a role in the recurrence of infections. Many studies have indicated an unusual high
prevalence of atopy in patients with CEA±Malmstrom et al. found that 17/31 (54%) of adolescents had
a positive allergy skin prick test [74]. Sistonen et al. reported that 37/101 (37%) of CEA± TEF cases had
at least one positive reaction to common allergens in the skin prick test and that multiple sensitizations
were associated with current respiratory symptoms [78]. Finally, more recently, Gatzinsky et al. found
specific IgE in 11/28 (39%) adult patients who underwent CEA in 1968–1983 [80].
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Table 3. Reasons for the persistence of respiratory morbidity in patients with repaired congenital
esophageal atresia and tracheoesophageal fistula.
Reasons
• Malformation itself
• Acquired damage after the surgical repair
• Co-morbidities
• Recurrence of lower respiratory tract infections
• Atopy
• Smoking habits
The mechanism by which patients with repaired CEA ± TEF have an increased prevalence of
atopy or allergies is still controversial. However, the most reasonable hypothesis is a dysregulation
of the respiratory epithelial barrier related to the malformation itself which can modify the tissue
homeostasis and the innate immune response [81]. Additionally, bronchiectasis is a quite common
finding. The onset of bronchiectasis is strictly related to recurrent pneumonia, and this condition
has an incidence ranging from 14% to 17% in CEA ± TEF patients [82,83]. Bronchiectasis has been
recognized as an irreversible condition which is, in turn, a risk factor for pulmonary exacerbations
and respiratory impairment [84]. Additionally, chronic cough and/or barking cough are other very
common conditions occurring in this population beginning in the first years of life and lasting to
adulthood, but these symptoms seem to improve with age. In a study of 43 children born from 2011
to 2014, chronic cough was described in 72% of cases [85], whereas other studies of adolescents and
adults reported a prevalence ranging from 19% to 34% [78,80,86].
Wheezing and dyspnea are frequent complaints of patients with repaired CEA± TEF, and a higher
incidence of doctor-diagnosed asthma has also been reported compared to the general population [78].
In the literature, the prevalence of asthma among patients with CEA varies between 16% and
30% [74,78,80]. However, a history of asthma-like symptoms, such as wheeze, recurrent cough,
and breathlessness during respiratory infections, is not pathognomonic for bronchial asthma.
Additionally, conditions such as tracheomalacia, airway malformations, or GERD may mimic asthma,
which can be overestimated.
Many studies have described pulmonary function abnormalities in patients with repaired
CEA ± TEF, including both restrictive and obstructive ventilatory patterns; other pediatric studies
have instead reported normal lung function [80]. Interestingly, in a longitudinal study correlating
respiratory symptoms, pulmonary function tests, and bronchial hyperreactivity with endobronchial
biopsy performed at the age of <3, 3 to 7, and >7 years, the authors did not find signs of bronchial
remodelling or chronic inflammation, which are typical changes that result from asthma. Despite
recurrent respiratory infections, the presence of atopy and esophageal symptoms during childhood
reduced pulmonary function during adolescence [74].
Our recent study of 13 children, operated on at a single center with a median 9-year follow-up
(range 5–15 years) period, recorded a number of lower respiratory tract infections substantially similar
to a control group of healthy children, although the infections were more severe in children with
CEA ± TEF, who frequently needed hospitalization. An allergic sensitization was found in 23% of
cases and in 7% of controls. The exhaled fraction of nitric oxide results were similar in the two groups
(11 parts per billion, ppb, in cases and 12 ppb in controls), highlighting that the clinical relevance
of nitric oxide was limited in this population. CEA patients had a mean forced vital capacity of
73% (104% in controls) and a mean forced expiratory volume in one second of 82% (95% in controls).
Pulmonary function tests have only documented normal respiratory pattern or mild restrictive findings.
No patient in the case group had an obstructive impairment. Residual volume and diffusion capacity
were normal (96% and 103%, respectively), whereas the measurement of the resistance with the
interruption technique has demonstrated higher baseline values in cases (230%) than in controls
(104%), mostly without pharmacologic reversibility. It is likely that these findings are suggestive of
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narrowed airways and poor lung growth rather than of bronchial asthma, showing the importance of
pulmonary function tests in these patients.
9. Conclusions
Currently, most children born with CEA ± TEF survive into adulthood, but many comorbidities,
mainly the esophageal and respiratory issues, may persist throughout life. Pulmonary impairment
involves many underlying mechanisms, which begin in the first years of life. This period coincides
with a critical window for the growth of lungs and alveolar development. Therefore, early detection
and management of pulmonary morbidity may be important to prevent impairment in pulmonary
function and serious long-term complications. To obtain a successful outcome, it is fundamental to
ensure a standardized, multidisciplinary follow-up that must continue until adulthood. A consensus
protocol involving pediatricians, pulmonologists, allergists, gastroenterologists, otolaryngologists,
surgeons, and physiotherapists is urgently needed to define the optimal multidisciplinary approach.
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